08/06/2026
With no validated treatments or vaccines yet, and limited diagnostics for Bundibugyo virus disease, R&D and funding must embed transparent and enforceable conditions from the outset to guarantee timely, sustainable access to affordable medical tools for the most affected communities.
Read our statement sharing principles to follow for equitable access to medical tools for Ebola disease caused by Bundibugyo virus: https://msfaccess.org/principles-equitable-access-medical-tools-ebola-disease-caused-bundibugyo-virus?utm_source=fb